Evidence method
Level · gp.fundamentals.capex_revenue_ratio
41.24% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CRNX · Dec 31, 2019
Crinetics Pharmaceuticals, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001564590-20-009365General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-3887.76% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
-50.86% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-4512.32% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3479.13% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
527.58% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History14 statesSelf-history eligible
Sep 30, 20190/6 normalizedLevel 3Dec 31, 20190/6 normalizedLevel 3Mar 31, 20200/6 normalizedLevel 3Dec 31, 20200/6 normalizedLevel 3Mar 31, 20235/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Mar 31, 20256/6 normalizedLevel 3Jun 30, 20256/6 normalizedLevel 3Dec 31, 20256/8 normalizedLevel 3Mar 31, 20266/8 normalizedLevel 3Jun 30, 20266/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.00%
- Current
- 41.24%
- Delta
- 41.24%
- Previous
- -2694.46%
- Current
- -3887.76%
- Delta
- -1193.31%
- Previous
- -7.85%
- Current
- -50.86%
- Delta
- -43.02%
- Previous
- -3015.64%
- Current
- -4512.32%
- Delta
- -1496.68%
- Previous
- 2341.19%
- Current
- 3479.13%
- Delta
- 1137.94%
- Previous
- 367.13%
- Current
- 527.58%
- Delta
- 160.45%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CRNX Fundamental State →Transitioned To · CRNX Fundamental State →Transitioned To · CRNX CAPEX_INTENSITY_INCREASED →Transitioned To · CRNX CASH_GENERATION_DECREASED →Transitioned To · CRNX GROWTH_DECREASED →Transitioned To · CRNX PROFITABILITY_DECREASED →Transitioned To · CRNX R_AND_D_INTENSITY_INCREASED →Transitioned To · CRNX SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.